Oral pilocarpine (Salagen)--a recently approved salivary stimulant.
Wynn
R L
RL
Department of Pharmacology, Dental School, University of Maryland at Baltimore, USA.
D000284:Administration, Oral; D016371:Cranial Irradiation / Q000009:adverse effects; D017277:Drug Approval; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D010277:Parasympathomimetics / Q000008:administration & dosage*; D010862:Pilocarpine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D012472:Salivation / Q000187:drug effects*; D013268:Stimulation, Chemical; D014481:United States; D014486:United States Food and Drug Administration; D014987:Xerostomia / Q000188:drug therapy* / Q000209:etiology
D010277:Parasympathomimetics; D010862:Pilocarpine